Cost-Effectiveness Analysis of Ranibizumab versus Verteporfin Photodynamic Therapy, Pegaptanib Sodium, and Best Supportive Care for the Treatment of Age-Related Macular Degeneration in Greece-Reference-Cited by-同舟云学术

Cost-Effectiveness Analysis of Ranibizumab versus Verteporfin Photodynamic Therapy, Pegaptanib Sodium, and Best Supportive Care for the Treatment of Age-Related Macular Degeneration in Greece

Published:2012-02 Issue:2 Volume:34 Page:446-456
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Athanasakis Kostas,Fragoulakis Vasilios,Tsiantou Vasiliki,Masaoutis Panagiotis,Maniadakis Nikolaos,Kyriopoulos John

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference35 articles.

2. Epidemiology of age-related maculopathy;Vingerling;Epidemiol Rev,1995

3. New approaches in the management of choroidal neovascular membrane in age-related macular degeneration;Verma;Indian J Ophthalmol,2000

4. Cataracts and macular degeneration in older Americans;Klein;Arch Ophthalmol,1982

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does a Standard Cost-Effectiveness Threshold Exist? The Case of Greece;Value in Health Regional Issues;2023-07

2. Quality-adjusted life years in macular oedema due to age-related macular degeneration, diabetes and central retinal vein occlusion: the impact of anti-VEGF agents in a tertiary centre in Greece;International Ophthalmology;2022-04-13

3. The economics of vision impairment and its leading causes: A systematic review;eClinicalMedicine;2022-04

4. A Systematic Review of Economic Studies Evaluating Ophthalmic Drugs: An Analysis of the Health-state Utilities;Ophthalmic Epidemiology;2020-07-21

A Multicenter, Cross-Sectional Study of the Incidence of Major Macular Diseases That Cause Visual Impairment and Require Therapeutic Intervention in Greece: The ADVICE Study

;Clinical Ophthalmology;2020-05